International Agency for Research on Cancer (IARC) - Summaries & Evaluations
2,4,6-TRIS(1-AZIRIDINYL)-s-TRIAZINE
VOL.: 9 (1975) (p. 95)
CAS No.: 51-18-3
Chem. Abstr. Name: 2,4,6-Tris(1-aziridinyl)-1,3,5-triazine
5. Summary of Data Reported and Evaluation
5.1 Animal carcinogenicity data
2,4,6-Tris(l-aziridinyl)-s-triazine is carcinogenic in mice following
its intraperitoneal injection, producing an increase in the incidence
of ovarian, thymic and lung tumours. It also acted as an initiator of
skin carcinogenesis. In rats it produced sarcomas at the site of its
subcutaneous injection.
5.2 Human carcinogenicity data
No case reports or epidemiological studies were available to the
Working Group.
Subsequent evaluation: Suppl. 7 (1987) (p. 73: Group 3)
For definition of Groups, see Preamble Evaluation.
Synonyms
- ENT 25,296
- M-9500
- Persistol
- Persistol Ho 1/193
- R-246
- SK-1133
- TEM
- TET
- Tretamine
- Triamelin
- 1,1',l"-s-Triazine-2,4,6-triyltrisaziridine
- Triaziridinyl triazine
- Triethanomelamine
- 2,4,6-Triethyleneimino-1,3,5-triazine
- Triethylenenelamine
- 2,4,6-Triethylenimino-s-triazine
- 2,4,6-Tris(l'-aziridinyl)-1,3,5-triazine
- 2,4,6-Tris(ethyleneimino)-s-triazine
- Tris(ethyleneimino)triazine
- 2,4,6-Tris(ethylenimino)-s-triazine
Last updated: 21 March 1998